After two federal agencies recommended a pause in use of the Johnson & Johnson vaccine, the Arizona Department of Health Services (ADHS) announced on Friday it is advising providers to resume use of the one-dose vaccine.

The ADHS announcement follows the Centers for Disease Control and Prevention (CDC) and U.S. Food and Drug Administration (FDA) advisory expressing confidence that the vaccine is safe and effective in preventing COVID-19.

The two federal agencies had recommended a pause in use of the Johnson & Johnson vaccine based on six reported U.S. cases, out of 6.8 million doses administered nationally, of a rare and severe type of blood clot in vaccinated individuals. The ADHS determination said available data suggest the chance of this reaction is very low, though the CDC and FDA said they will remain vigilant in continuing to investigate this risk.

So far in Arizona, 226,300 doses of the Johnson & Johnson vaccine have been allocated, of which approximately 122,000 have been administered.

Information provided with the vaccine will advise patients about extremely low potential for thrombosis-thrombocytopenia syndrome, which involves blood clots and low blood platelet counts. This very rare syndrome was identified primarily in females between the ages of 18 and 49.

Information about all vaccination sites across Arizona can be found at azhealth.gov/findvaccine.